MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies _ Stroke
DiaMedica Therapeutics Inc. (NASDAQ:DMAC)*
Organization & Developments: DiaMedica
Parents
DiaMedica Therapeutics Inc. (NASDAQ:DMAC)*
Children
*Clinical-stage biopharmaceutical company developing novel recombinant (synthetic) proteins.
*The Company is using its patented and licensed technologies to establish the Company as a leader in the development and commercialization of novel recombinant proteins to treat kidney and neurological diseases.
*The primary focus is on chronic kidney disease ("CKD") and acute ischemic stroke ("AIS").
2022: DiaMedica Therapeutics (DMAC) Investor Presentation - Slideshow_ seekingalpha.com
2025: DiaMedica Therapeutics: Interesting Work In Treating Ischemic Stroke
Jumps
Finance & Acquisitions: DiaMedica
Key People: DiaMedica